Anebulo Pharmaceuticals

Anebulo Pharmaceuticals is a clinical-stage biotechnology company developing new solutions for patients with cannabinoid overdose and drug addiction. Our lead candidate product, ANEB-001, is designed to reverse the negative effects of cannabinoid overdose within 1 hour of administration. Symptoms and signs of cannabinoid overdose range from deep sedation to anxiety and panic, to psychosis accompanied by hallucinations.